Correlation Between MoonLake Immunotherapeuti and Standard Biotools

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MoonLake Immunotherapeuti and Standard Biotools at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MoonLake Immunotherapeuti and Standard Biotools into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MoonLake Immunotherapeutics and Standard Biotools, you can compare the effects of market volatilities on MoonLake Immunotherapeuti and Standard Biotools and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MoonLake Immunotherapeuti with a short position of Standard Biotools. Check out your portfolio center. Please also check ongoing floating volatility patterns of MoonLake Immunotherapeuti and Standard Biotools.

Diversification Opportunities for MoonLake Immunotherapeuti and Standard Biotools

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between MoonLake and Standard is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding MoonLake Immunotherapeutics and Standard Biotools in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Biotools and MoonLake Immunotherapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MoonLake Immunotherapeutics are associated (or correlated) with Standard Biotools. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Biotools has no effect on the direction of MoonLake Immunotherapeuti i.e., MoonLake Immunotherapeuti and Standard Biotools go up and down completely randomly.

Pair Corralation between MoonLake Immunotherapeuti and Standard Biotools

Given the investment horizon of 90 days MoonLake Immunotherapeuti is expected to generate 30.5 times less return on investment than Standard Biotools. In addition to that, MoonLake Immunotherapeuti is 3.53 times more volatile than Standard Biotools. It trades about 0.0 of its total potential returns per unit of risk. Standard Biotools is currently generating about 0.1 per unit of volatility. If you would invest  124.00  in Standard Biotools on August 30, 2025 and sell it today you would earn a total of  26.00  from holding Standard Biotools or generate 20.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MoonLake Immunotherapeutics  vs.  Standard Biotools

 Performance 
       Timeline  
MoonLake Immunotherapeuti 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days MoonLake Immunotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, MoonLake Immunotherapeuti is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Standard Biotools 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Standard Biotools are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Standard Biotools sustained solid returns over the last few months and may actually be approaching a breakup point.

MoonLake Immunotherapeuti and Standard Biotools Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MoonLake Immunotherapeuti and Standard Biotools

The main advantage of trading using opposite MoonLake Immunotherapeuti and Standard Biotools positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MoonLake Immunotherapeuti position performs unexpectedly, Standard Biotools can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Biotools will offset losses from the drop in Standard Biotools' long position.
The idea behind MoonLake Immunotherapeutics and Standard Biotools pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal